# EDGAR Filing Document

**Accession Number:** 0001900304
**File Stem:** 0001654954-25-012331
**Filing Date:** 2025-10
**Character Count:** 5116
**Document Hash:** 2a98f8475a1b0d8c893fb92bcbc094a1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-25-012331.hdr.sgml**: 20251030

**ACCESSION NUMBER**: 0001654954-25-012331

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20251030

**FILED AS OF DATE**: 20251030

**DATE AS OF CHANGE**: 20251030

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Haleon plc
- **CENTRAL INDEX KEY:** 0001900304
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41411
- **FILM NUMBER:** 251432133

**BUSINESS ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY
- **BUSINESS PHONE:** 44 1932 822000

**MAIL ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DRVW 2022 Ltd
- **DATE OF NAME CHANGE:** 20211217

**UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

 **FORM 6-K**

 **REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934**

 **For the month of October 2025**

 **Commission File Number: 001-41411**

 **Haleon plc**

(Translation of registrant's name into English)

 **Building 5, First Floor, The Heights,**

 **Weybridge, Surrey, KT13 0NY**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

 **EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 99.1 | 30 October 2025 - "Haleon 2025 Q3 Trading Statement" |
| [99.2](q32025pressreleasevfff.pdf) | 30 October 2025 - "[Haleon 2025 Q3 Trading Statement](q32025pressreleasevfff.pdf)" |

---

99.1 ![](a4049f-62700440000.jpg)

 **Haleon plc: 2025 Q3 Trading Statement**

 **30 October 2025:** Haleon plc (the "Company" or "Haleon") today announces its Q3 trading statement for the year ending 31 December 2025 is available at: <u>http://www.rns-pdf.londonstockexchange.com/rns/4049F_1-2025-10-29.pdf</u><u>.</u>

The Q3 trading statement will also be available on the Haleon website <u>www.haleon.com/investors</u>, and has been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at <u>https://data.fca.org.uk/#/nsm/nationalstoragemechanism</u>.

 **Presentation for analysts and shareholders**

A short presentation followed by Q&A will be hosted by Dawn Allen, Chief Financial Officer at 9:00am GMT (10:00am CET) on 30 October 2025, which can be accessed at <u>www.haleon.com/investors</u><u>.</u> 

For analysts and shareholders wishing to ask questions on the Q&A call, please use the dial-in details below which will have a Q&A facility:

---

| | |
|:---|:---|
| UK: | +44 (0) 808 189 0158 |
| US: | +1 855 979 6654 |
| All other: | +44 (0) 203 936 2999 |
| Passcode: | 407228 |

---

An archived webcast of the Q&A call will be available later on the day of the results and can be accessed at <u>www.haleon.com/investors</u><u>.</u>

 **Amanda Mellor** 

 **Company Secretary** 

 **Enquiries**

---

| | | | |
|:---|:---|:---|:---|
| **Investors** | **Investors** | **Media** | **Media** |
| Jo Russell | +44 7787 392441 | Zoë Bird | +44 7736 746167 |
| Rakesh Patel | +44 7552 484646 | Victoria Durman | +44 7894 505730 |
| <br> Email: <u>investor-relations@haleon.com</u> | <br> Email: <u>investor-relations@haleon.com</u> | <br> Email: corporate.media@haleon.com  | <br> Email: corporate.media@haleon.com  |

---

 **About Haleon**

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as *Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren* - are built on trusted science, innovation and deep human understanding.

For more information please visit <u>www.haleon.com</u>.

 **SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **HALEON PLC**<br> *(Registrant)* | **HALEON PLC**<br> *(Registrant)* |
| Date: October 30, 2025 | By: | /s/ Amanda Mellor | /s/ Amanda Mellor |
|  |  | Name: | Amanda Mellor |
|  |  | Title: | Company Secretary |

---

### Attached PDF Documents

**Attachment 1:** `q32025pressreleasevfff.pdf`

_No text found in this document._